Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

A Threshold of Meaning for Work Disability Improvement in Psoriatic Arthritis Measured by the Work Productivity and Activity Impairment Questionnaire.

Tillett W, Lin CY, Zbrozek A, Sprabery AT, Birt J.

Rheumatol Ther. 2019 Sep;6(3):379-391. doi: 10.1007/s40744-019-0155-5. Epub 2019 Jun 1.

2.

The contribution of joint and skin improvements to the health-related quality of life of patients with psoriatic arthritis: a post hoc analysis of two randomised controlled studies.

Kavanaugh A, Gottlieb A, Morita A, Merola JF, Lin CY, Birt J, Shuler CL, Hufford MM, Thaçi D.

Ann Rheum Dis. 2019 Sep;78(9):1215-1219. doi: 10.1136/annrheumdis-2018-215003. Epub 2019 May 21.

3.

Achieving minimal disease activity in psoriatic arthritis predicts meaningful improvements in patients' health-related quality of life and productivity.

Coates LC, Orbai AM, Morita A, Benichou O, Kerr L, Adams DH, Shuler CL, Birt J, Helliwell PS.

BMC Rheumatol. 2018 Aug 13;2:24. doi: 10.1186/s41927-018-0030-y. eCollection 2018.

4.

Burden and Disease Characteristics of Patients with Psoriatic Arthritis: A Population-based Cross-sectional Study.

Tekin HG, Wu JJ, Burge R, Birt J, Egeberg A.

J Rheumatol. 2019 Jul;46(7):716-720. doi: 10.3899/jrheum.180670. Epub 2019 Mar 1.

PMID:
30824662
5.

Ixekizumab and complete resolution of enthesitis and dactylitis: integrated analysis of two phase 3 randomized trials in psoriatic arthritis.

Gladman DD, Orbai AM, Klitz U, Wei JC, Gallo G, Birt J, Rathmann S, Shrom D, Marzo-Ortega H.

Arthritis Res Ther. 2019 Jan 29;21(1):38. doi: 10.1186/s13075-019-1831-0.

6.

Patient Perspective on the Burden of Skin and Joint Symptoms of Psoriatic Arthritis: Results of a Multi-National Patient Survey.

Merola JF, Shrom D, Eaton J, Dworkin C, Krebsbach C, Shah-Manek B, Birt J.

Rheumatol Ther. 2019 Mar;6(1):33-45. doi: 10.1007/s40744-018-0135-1. Epub 2019 Jan 4.

7.

Ixekizumab improves patient-reported outcomes in patients with active psoriatic arthritis and inadequate response to tumour necrosis factor inhibitors: SPIRIT-P2 results to 52 weeks.

Kavanaugh A, Marzo-Ortega H, Vender R, Wei CC, Birt J, Adams DH, Benichou O, Lin CY, Nash P.

Clin Exp Rheumatol. 2019 Jul-Aug;37(4):566-574. Epub 2018 Nov 19.

8.

PsAID12 Provisionally Endorsed at OMERACT 2018 as Core Outcome Measure to Assess Psoriatic Arthritis-specific Health-related Quality of Life in Clinical Trials.

Orbai AM, Holland R, Leung YY, Tillett W, Goel N, Christensen R, McHugh N, Gossec L, de Wit M, Højgaard P, Coates LC, Mease PJ, Birt J, Fallon L, FitzGerald O, Ogdie A, Shea B, Strand V, Duffin KC, Tugwell P, Beaton D, Gladman DD.

J Rheumatol. 2019 Aug;46(8):990-995. doi: 10.3899/jrheum.181077. Epub 2018 Dec 15.

PMID:
30554154
9.

Skin Involvement in Psoriatic Arthritis Worsens Overall Disease Activity, Patient-Reported Outcomes, and Increases Healthcare Resource Utilization: An Observational, Cross-Sectional Study.

de Vlam K, Merola JF, Birt JA, Sandoval DM, Lobosco S, Moon R, Milligan G, Boehncke WH.

Rheumatol Ther. 2018 Dec;5(2):423-436. doi: 10.1007/s40744-018-0120-8. Epub 2018 Jul 6.

10.

Ixekizumab improves patient-reported outcomes up to 52 weeks in bDMARD-naïve patients with active psoriatic arthritis (SPIRIT-P1).

Gottlieb AB, Strand V, Kishimoto M, Mease P, Thaçi D, Birt J, Lee CH, Shuler CL, Lin CY, Gladman DD.

Rheumatology (Oxford). 2018 Oct 1;57(10):1777-1788. doi: 10.1093/rheumatology/key161.

11.

SIgA, TGF-β1, IL-10, and TNFα in Colostrum Are Associated with Infant Group B Streptococcus Colonization.

Le Doare K, Bellis K, Faal A, Birt J, Munblit D, Humphries H, Taylor S, Warburton F, Heath PT, Kampmann B, Gorringe A.

Front Immunol. 2017 Oct 20;8:1269. doi: 10.3389/fimmu.2017.01269. eCollection 2017.

12.

Patient burden of Sjögren's: a comprehensive literature review revealing the range and heterogeneity of measures used in assessments of severity.

Hammitt KM, Naegeli AN, van den Broek RWM, Birt JA.

RMD Open. 2017 Sep 17;3(2):e000443. doi: 10.1136/rmdopen-2017-000443. eCollection 2017.

13.

Association between functional antibody against Group B Streptococcus and maternal and infant colonization in a Gambian cohort.

Le Doare K, Faal A, Jaiteh M, Sarfo F, Taylor S, Warburton F, Humphries H, Birt J, Jarju S, Darboe S, Clarke E, Antonio M, Foster-Nyarko E, Heath PT, Gorringe A, Kampmann B.

Vaccine. 2017 May 19;35(22):2970-2978. doi: 10.1016/j.vaccine.2017.04.013. Epub 2017 Apr 24.

14.

Sjögren's syndrome: managed care data from a large United States population highlight real-world health care burden and lack of treatment options.

Birt JA, Tan Y, Mozaffarian N.

Clin Exp Rheumatol. 2017 Jan-Feb;35(1):98-107. Epub 2016 Oct 7.

PMID:
27749234
15.

Lack of evidence for the efficacy of enhanced surveillance compared to other specific interventions to control neonatal healthcare-associated infection outbreaks.

Birt J, Le Doare K, Kortsalioudaki C, Lawn J, Heath PT, Sharland M.

Trans R Soc Trop Med Hyg. 2016 Feb;110(2):98-106. doi: 10.1093/trstmh/trv116. Review.

16.

Patient characteristics and treatment patterns for patients with benign prostatic hyperplasia, erectile dysfunction or co-occurring benign prostatic hyperplasia and erectile dysfunction in general practices in the UK: a retrospective observational study.

Ilo D, Raluy-Callado M, Graham-Clarke P, Sadasivan R, Birt J, Donaldson R, Zhu E, Kirby MG, Neasham D.

Int J Clin Pract. 2015 Aug;69(8):853-62. doi: 10.1111/ijcp.12657. Epub 2015 May 25.

PMID:
26011100
17.

Patient Characteristics and Medication Treatment Patterns Among Men With Erectile Dysfunction (Ed), Lower Urinary Tract Symptoms Secondary To Benign Prostatic Hyperplasia (Bph-Luts), Or Co-Occurring Ed and Bph-Luts In the Uk Primary Care Setting.

Ilo D, Raluy-Callado M, Graham-Clarke P, Donaldson R, Birt J, Sadasivan R, Zhu Y, Neasham D.

Value Health. 2014 Nov;17(7):A521. doi: 10.1016/j.jval.2014.08.1629. Epub 2014 Oct 26. No abstract available.

18.

Predictive models for water sources with high susceptibility for bromine-containing disinfection by-product formation: implications for water treatment.

Watson K, Farré MJ, Birt J, McGree J, Knight N.

Environ Sci Pollut Res Int. 2015 Feb;22(3):1963-78. doi: 10.1007/s11356-014-3408-4. Epub 2014 Aug 28.

PMID:
25163557
19.

Exploration of claims-based utilization measures for detecting potential nonmedical use of prescription drugs.

Birt J, Johnston J, Nelson D.

J Manag Care Spec Pharm. 2014 Jun;20(6):639-46.

20.

Changes in low-density lipoprotein cholesterol levels after discharge for acute myocardial infarction in a real-world patient population.

Arnold SV, Kosiborod M, Tang F, Zhao Z, McCollam PL, Birt J, Spertus JA.

Am J Epidemiol. 2014 Jun 1;179(11):1293-300. doi: 10.1093/aje/kwu060. Epub 2014 Apr 16.

21.

Patterns of statin initiation, intensification, and maximization among patients hospitalized with an acute myocardial infarction.

Arnold SV, Kosiborod M, Tang F, Zhao Z, Maddox TM, McCollam PL, Birt J, Spertus JA.

Circulation. 2014 Mar 25;129(12):1303-9. doi: 10.1161/CIRCULATIONAHA.113.003589. Epub 2014 Feb 4.

22.
23.

An enriched multimedia eBook application to facilitate learning of anatomy.

Stirling A, Birt J.

Anat Sci Educ. 2014 Jan-Feb;7(1):19-27. doi: 10.1002/ase.1373. Epub 2013 May 6.

PMID:
23650104
24.

Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial.

UKMND-LiCALS Study Group, Morrison KE, Dhariwal S, Hornabrook R, Savage L, Burn DJ, Khoo TK, Kelly J, Murphy CL, Al-Chalabi A, Dougherty A, Leigh PN, Wijesekera L, Thornhill M, Ellis CM, O'Hanlon K, Panicker J, Pate L, Ray P, Wyatt L, Young CA, Copeland L, Ealing J, Hamdalla H, Leroi I, Murphy C, O'Keeffe F, Oughton E, Partington L, Paterson P, Rog D, Sathish A, Sexton D, Smith J, Vanek H, Dodds S, Williams TL, Steen IN, Clarke J, Eziefula C, Howard R, Orrell R, Sidle K, Sylvester R, Barrett W, Merritt C, Talbot K, Turner MR, Whatley C, Williams C, Williams J, Cosby C, Hanemann CO, Iman I, Philips C, Timings L, Crawford SE, Hewamadduma C, Hibberd R, Hollinger H, McDermott C, Mils G, Rafiq M, Shaw PJ, Taylor A, Waines E, Walsh T, Addison-Jones R, Birt J, Hare M, Majid T.

Lancet Neurol. 2013 Apr;12(4):339-45. doi: 10.1016/S1474-4422(13)70037-1. Epub 2013 Feb 27. Erratum in: Lancet Neurol. 2013 Sep;12(9):846.

25.

Drug reimbursement recommendations by the National Institute for Health and Clinical Excellence: have they impacted the National Health Service budget?

Mauskopf J, Chirila C, Birt J, Boye KS, Bowman L.

Health Policy. 2013 Apr;110(1):49-59. doi: 10.1016/j.healthpol.2013.01.017. Epub 2013 Feb 20.

PMID:
23434292
26.

Elevated peritoneal fluid TNF-α incites ovarian early growth response factor 1 expression and downstream protease mediators: a correlation with ovulatory dysfunction in endometriosis.

Birt JA, Nabli H, Stilley JA, Windham EA, Frazier SR, Sharpe-Timms KL.

Reprod Sci. 2013 May;20(5):514-23. doi: 10.1177/1933719113477479. Epub 2013 Feb 20.

27.

Do different clinical evidence bases lead to discordant health-technology assessment decisions? An in-depth case series across three jurisdictions.

Spinner DS, Birt J, Walter JW, Bowman L, Mauskopf J, Drummond MF, Copley-Merriman C.

Clinicoecon Outcomes Res. 2013;5:69-85. doi: 10.2147/CEOR.S39624. Epub 2013 Jan 30.

28.

Relationship between financial impact and coverage of drugs in Australia.

Mauskopf J, Chirila C, Masaquel C, Boye KS, Bowman L, Birt J, Grainger D.

Int J Technol Assess Health Care. 2013 Jan;29(1):92-100. doi: 10.1017/S0266462312000724. Epub 2012 Dec 10.

29.

Coexisting lower urinary tract symptoms and erectile dysfunction: a systematic review of epidemiological data.

Seftel AD, de la Rosette J, Birt J, Porter V, Zarotsky V, Viktrup L.

Int J Clin Pract. 2013 Jan;67(1):32-45. doi: 10.1111/ijcp.12044. Epub 2012 Oct 22. Review.

PMID:
23082930
30.

Willingness to pay for obesity pharmacotherapy.

Doyle S, Lloyd A, Birt J, Curtis B, Ali S, Godbey K, Sierra-Johnson J, Halford JC.

Obesity (Silver Spring). 2012 Oct;20(10):2019-26. doi: 10.1038/oby.2011.387. Epub 2012 Feb 2. Review.

31.

Cellular and molecular basis for endometriosis-associated infertility.

Stilley JA, Birt JA, Sharpe-Timms KL.

Cell Tissue Res. 2012 Sep;349(3):849-62. Review.

32.

Methodologies used in cost-effectiveness models for evaluating treatments in major depressive disorder: a systematic review.

Zimovetz EA, Wolowacz SE, Classi PM, Birt J.

Cost Eff Resour Alloc. 2012 Feb 1;10(1):1. doi: 10.1186/1478-7547-10-1.

33.

Differences among formulary submission guidelines: implications for health technology assessment.

Mauskopf J, Walter J, Birt J, Bowman L, Copley-Merriman C, Drummond M.

Int J Technol Assess Health Care. 2011 Jul;27(3):261-70. doi: 10.1017/S0266462311000274.

PMID:
21756414
34.

Neutralizing TIMP1 restores fecundity in a rat model of endometriosis and treating control rats with TIMP1 causes anomalies in ovarian function and embryo development.

Stilley JA, Birt JA, Nagel SC, Sutovsky M, Sutovsky P, Sharpe-Timms KL.

Biol Reprod. 2010 Aug 1;83(2):185-94. doi: 10.1095/biolreprod.109.083287. Epub 2010 Apr 21.

35.

Economic burden of multiple sclerosis: a systematic review of the literature.

Naci H, Fleurence R, Birt J, Duhig A.

Pharmacoeconomics. 2010;28(5):363-79. doi: 10.2165/11532230-000000000-00000. Review.

PMID:
20402540
36.

Inflammatory cytokines differentially up-regulate human endometrial haptoglobin production in women with endometriosis.

Sharpe-Timms KL, Nabli H, Zimmer RL, Birt JA, Davis JW.

Hum Reprod. 2010 May;25(5):1241-50. doi: 10.1093/humrep/deq032. Epub 2010 Feb 22.

37.

The impact of increasing neurological disability of multiple sclerosis on health utilities: a systematic review of the literature.

Naci H, Fleurence R, Birt J, Duhig A.

J Med Econ. 2010 Mar;13(1):78-89. doi: 10.3111/13696990903543085. Review.

PMID:
20047364
38.

Adherence to guidelines for sensitivity analysis: cost-effectiveness analyses of dual oral antiplatelet therapy.

Mauskopf JA, Boye KS, Schmitt C, McCollam P, Birt J, Juniper MD, Bakhai A.

J Med Econ. 2009 Jun;12(2):141-53. doi: 10.3111/13696990903123813. Review.

PMID:
19630490
39.

Patience for patients.

Birt J.

Adv Nurse Pract. 2007 Dec;15(12):100. No abstract available.

PMID:
20014680
40.

Persistent dyspnea with HF.

Birt J.

Adv Nurse Pract. 2006 Sep;14(9):22-3. No abstract available.

PMID:
16972438
41.

Patients with inflammatory bowel disease are at risk for vaccine-preventable illnesses.

Melmed GY, Ippoliti AF, Papadakis KA, Tran TT, Birt JL, Lee SK, Frenck RW, Targan SR, Vasiliauskas EA.

Am J Gastroenterol. 2006 Aug;101(8):1834-40. Epub 2006 Jun 30.

PMID:
16817843
42.

Safety and efficacy of adalimumab (D2E7) in Crohn's disease patients with an attenuated response to infliximab.

Papadakis KA, Shaye OA, Vasiliauskas EA, Ippoliti A, Dubinsky MC, Birt J, Paavola J, Lee SK, Price J, Targan SR, Abreu MT.

Am J Gastroenterol. 2005 Jan;100(1):75-9.

PMID:
15654784
43.

Management of weight gain associated with antipsychotics.

Birt J.

Ann Clin Psychiatry. 2003 Mar;15(1):49-58. Review.

PMID:
12839432
44.

Parent and adolescent adjustment to pediatric cancer: associations with coping, social support, and family function.

Trask PC, Paterson AG, Trask CL, Bares CB, Birt J, Maan C.

J Pediatr Oncol Nurs. 2003 Jan-Feb;20(1):36-47.

PMID:
12569433
45.

Characterization of the precipitants of hospitalization for heart failure decompensation.

Bennett SJ, Huster GA, Baker SL, Milgrom LB, Kirchgassner A, Birt J, Pressler ML.

Am J Crit Care. 1998 May;7(3):168-74.

PMID:
9579241
46.

Syndrome of inappropriate secretion of antidiuretic hormone secondary to fluoxetine.

Blacksten JV, Birt JA.

Ann Pharmacother. 1993 Jun;27(6):723-4.

PMID:
8329791
47.

Medication compliance in elderly outpatients using twice-daily dosing and unit-of-use packaging.

Murray MD, Birt JA, Manatunga AK, Darnell JC.

Ann Pharmacother. 1993 May;27(5):616-21.

PMID:
8347915
48.

Using clinical data to determine vancomycin dosing parameters.

Birt JK, Chandler MH.

Ther Drug Monit. 1990 Mar;12(2):206-9.

PMID:
2315979
49.

Staffing by patient classification.

Birt J, Pullman RA.

J Am Health Care Assoc. 1976 Jul;2(4):75-8. No abstract available.

PMID:
1047079
50.

DISCUSSION ON ANÆSTHETICS IN CHILDREN.

Birt J.

Proc R Soc Med. 1926;19(Sect Anaesth):5-6. No abstract available.

PMID:
20909554

Supplemental Content

Support Center